Wave Life Sciences Ltd (WVE)
Wave Life Sciences stock today
Wave Life Sciences closed at $3.59 on October 30, 2026, down 1.10% on the day. Over the past year it returned -56.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $707 million.
| Period | WVE | S&P 500 (SPY) |
|---|---|---|
| 1 month | -3.0% | -0.9% |
| 3 months | -37.7% | +2.1% |
| Year to date | -78.9% | +11.7% |
| 1 year | -56.7% | +12.4% |
| 3 years | -33.9% | +88.5% |
| 5 years | -21.8% | +76.0% |
Key statistics
- Market value
- $707M
- Price / sales
- 10.0
- 52-week range
- $3.09 to $21.31
About Wave Life Sciences
Wave Life Sciences Ltd. develops therapies using RNA technology for genetic disorders.
Sector: Health Care
More on Wave Life Sciences
- Financials: revenue, earnings and segmentsRevenue -61% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $114.51 today
No forecast, no recommendation. This page describes Wave Life Sciences Ltd from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.